Donald J. Kyle

2.1k total citations
59 papers, 1.7k citations indexed

About

Donald J. Kyle is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Donald J. Kyle has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 19 papers in Genetics and 16 papers in Cellular and Molecular Neuroscience. Recurrent topics in Donald J. Kyle's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers), Chemical Synthesis and Analysis (14 papers) and Neuropeptides and Animal Physiology (11 papers). Donald J. Kyle is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers), Chemical Synthesis and Analysis (14 papers) and Neuropeptides and Animal Physiology (11 papers). Donald J. Kyle collaborates with scholars based in United States, Canada and Brazil. Donald J. Kyle's co-authors include Ronald M. Burch, Sarvajit Chakravarty, Qiang Zheng, João Β. Calixto, Laykea Tafesse, Jennifer A. Martin, Kenneth J. Valenzano, Victor I. Ilyin, Stephen G. Farmer and Chongwu Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Chemical Physics.

In The Last Decade

Donald J. Kyle

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald J. Kyle United States 25 897 476 440 323 214 59 1.7k
Gaétan Guillemette Canada 29 1.7k 1.9× 89 0.2× 617 1.4× 188 0.6× 131 0.6× 102 2.3k
Richard E. Middleton United States 18 2.0k 2.2× 67 0.1× 386 0.9× 206 0.6× 135 0.6× 27 2.4k
Stefan Dove Germany 30 1.5k 1.6× 73 0.2× 415 0.9× 210 0.7× 373 1.7× 75 2.1k
Robert Shorr United States 25 1.7k 1.9× 70 0.1× 531 1.2× 304 0.9× 147 0.7× 65 2.6k
Fabien Vincent United States 18 1.1k 1.2× 43 0.1× 148 0.3× 227 0.7× 156 0.7× 34 1.9k
Carlos Davio Argentina 28 1.3k 1.5× 102 0.2× 302 0.7× 215 0.7× 590 2.8× 117 2.8k
Donmienne Leung United States 18 1.2k 1.4× 107 0.2× 411 0.9× 212 0.7× 545 2.5× 26 2.9k
Albert J. Kooistra Netherlands 27 2.0k 2.3× 76 0.2× 662 1.5× 53 0.2× 256 1.2× 56 2.7k
Fahad Al‐Obeidi United States 24 1.5k 1.7× 48 0.1× 261 0.6× 100 0.3× 575 2.7× 57 2.8k
Julianne J. Sando United States 28 2.1k 2.4× 54 0.1× 432 1.0× 248 0.8× 85 0.4× 67 3.0k

Countries citing papers authored by Donald J. Kyle

Since Specialization
Citations

This map shows the geographic impact of Donald J. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald J. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald J. Kyle more than expected).

Fields of papers citing papers by Donald J. Kyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald J. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald J. Kyle. The network helps show where Donald J. Kyle may publish in the future.

Co-authorship network of co-authors of Donald J. Kyle

This figure shows the co-authorship network connecting the top 25 collaborators of Donald J. Kyle. A scholar is included among the top collaborators of Donald J. Kyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald J. Kyle. Donald J. Kyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Stephen M., et al.. (2014). Dibenzazepines and dibenzoxazepines as sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 25(1). 43–47. 13 indexed citations
2.
Wang, Baiyang, et al.. (2005). Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain. Archives of Biochemistry and Biophysics. 440(2). 148–157. 2 indexed citations
3.
Tafesse, Laykea, Qun Sun, Kenneth J. Valenzano, et al.. (2004). Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(22). 5513–5519. 36 indexed citations
4.
Tafesse, Laykea & Donald J. Kyle. (2004). An Efficient Parallel Synthesis of Capsazepine and Capsazepine Analogs. Combinatorial Chemistry & High Throughput Screening. 7(2). 153–161. 5 indexed citations
5.
6.
Chen, Zhengming, et al.. (2004). Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor. Bioorganic & Medicinal Chemistry Letters. 14(21). 5275–5279. 11 indexed citations
7.
Sun, Qun, et al.. (2003). Parallel Synthesis of a Biased Library of Thiazolidinones as Novel Sodium Channel Antagonists. Combinatorial Chemistry & High Throughput Screening. 6(5). 481–488. 4 indexed citations
8.
Höfer, Peter, Domenico Spina, Gary Douglas, et al.. (2003). Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294. Pulmonary Pharmacology & Therapeutics. 16(2). 97–104. 13 indexed citations
9.
Fröde, Tânia Sílvia, Tânia Beatriz Creczynski‐Pasa, Sarvajit Chakravarty, et al.. (1998). Oral anti-inflammatory action of NPC 18884, a novel bradykinin B2 receptor antagonist. European Journal of Pharmacology. 363(2-3). 179–187. 7 indexed citations
10.
Faußner, Alexander, H. Robinson, Sarvajit Chakravarty, et al.. (1997). Stable Expression of the Human Kinin B1 Receptor in Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 272(17). 11420–11425. 90 indexed citations
11.
Chakravarty, Sarvajit, Babu Mavunkel, R. Richard Goehring, & Donald J. Kyle. (1996). Novel bradykinin receptor antagonists from a structurally directed non-peptide combinatorial library. Immunopharmacology. 33(1-3). 61–67. 9 indexed citations
12.
Campos, Rafael O.P. de, et al.. (1996). Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist. European Journal of Pharmacology. 316(2-3). 277–286. 49 indexed citations
13.
Zheng, Qiang & Donald J. Kyle. (1994). Multiple copy sampling: Rigid versus flexible protein. Proteins Structure Function and Bioinformatics. 19(4). 324–329. 26 indexed citations
14.
Chakravarty, Sarvajit, Deidre Wilkins, & Donald J. Kyle. (1993). Design of potent, cyclic peptide bradykinin receptor antagonists from conformationally constrained linear peptides. Journal of Medicinal Chemistry. 36(17). 2569–2571. 26 indexed citations
15.
Otterbein, Leo E., Valerie C. Lowe, Donald J. Kyle, & Lalita Noronha‐Blob. (1993). Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsis. Inflammation Research. 39(S1). C125–C127. 9 indexed citations
16.
Burch, Ronald M. & Donald J. Kyle. (1992). Recent developments in the understanding of bradykinin receptors. Life Sciences. 50(12). 829–838. 85 indexed citations
17.
Kyle, Donald J., Jennifer A. Martin, Stephen G. Farmer, & Ronald M. Burch. (1991). Design and conformational analysis of several highly potent bradykinin receptor antagonists. Journal of Medicinal Chemistry. 34(3). 1230–1233. 70 indexed citations
18.
Burch, Ronald M. & Donald J. Kyle. (1991). Mass Receptor Screening for New Drugs. Pharmaceutical Research. 8(2). 141–147. 9 indexed citations
19.
Farmer, Stephen G., Ronald M. Burch, Donald J. Kyle, et al.. (1991). d‐Arg[Hyp3‐Thi5‐d‐Tic7‐Tic8]‐bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors. British Journal of Pharmacology. 102(4). 785–787. 33 indexed citations
20.
Ferkany, John W., Donald J. Kyle, Jonathon M. Willets, et al.. (1989). Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 100–109. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaétan Guillemette Breakdown of academic impact, for papers by Richard E. Middleton Breakdown of academic impact, for papers by Stefan Dove Breakdown of academic impact, for papers by Robert Shorr Breakdown of academic impact, for papers by Fabien Vincent Breakdown of academic impact, for papers by Carlos Davio Breakdown of academic impact, for papers by Donmienne Leung Breakdown of academic impact, for papers by Albert J. Kooistra Breakdown of academic impact, for papers by Fahad Al‐Obeidi Breakdown of academic impact, for papers by Julianne J. Sando
Rankless by CCL
2026